Switzerland | Imports and Exports | World | Pharmaceutical products | Value (US$) and Value Growth, YoY (%) | 2012 - 2023
The value of exports of commodity group 30 "Pharmaceutical products" from Switzerland totalled $ 99 billion in 2023. Sales of commodity group 30 from Switzerland went up by 1% compared to 2022: exports of commodity group 30 "Pharmaceutical products" went up by $ 980 million (cumulative exports of commodity group 30 from Switzerland amounted $98 billion in 2022)
Exports of commodity group 30 "Pharmaceutical products" amounted to 23% of total exports from Switzerland (cumulative merchandise exports from Switzerland totalled $ 419 billion in 2023). The share of commodity group 30 in total exports from Switzerland decreased by 0.925 p.p. compared to 2022 (it was 24% in 2022 and cumulative exports from Switzerland were equal to $ 400 billion).
Exports of commodity group 30 amounted to 99% of total sales of group 30 "Pharmaceutical products" from Switzerland in 2023 (the value of exports of commodity group 30 from Switzerland amounted to $99 billion in 2023). The share of exports of commodity group 30 in sales of commodity group 30 from Switzerland lowered by 0 p.p. compared to 2022 (it was 100% in 2022, and exports of commodity group 30 from Switzerland were $98 billion).
Where does Switzerland export Pharmaceutical products?
Top export destinations of "Pharmaceutical products" from Switzerland in 2023:
- USA with a share of 31% (30 billion US$)
- Germany with a share of 10.5% (10.4 billion US$)
- Slovenia with a share of 6.42% (6.36 billion US$)
- China with a share of 5.27% (5.22 billion US$)
- Italy with a share of 4.6% (4.56 billion US$)
- Japan with a share of 3.61% (3.57 billion US$)
- France with a share of 3.44% (3.41 billion US$)
- Canada with a share of 2.61% (2.59 billion US$)
- Belgium with a share of 2.44% (2.41 billion US$)
- United Kingdom with a share of 2.41% (2.38 billion US$)
Exports structure of 30 - Pharmaceutical products - from Switzerland in 2023 represented by the following main commodity groups:
- 52% (52 billion US$): 3002 - Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc
- 45% (45 billion US$): 3004 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale
- 0.624% (618 million US$): 3003 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale
- 0.59% (584 million US$): 3006 - Pharmaceutical goods specified in Note 4 to this Chapter.
- 0.04% (39 million US$): 3005 - Wadding, gauze, bandages and similar articles (for example, dressings, adhesive plasters, poultices), impregnated or coated with pharmaceutical substances or put up in forms or packings for retail sale for medical, surgical, dental or veterinary purposes.
- 0.015% (15.3 million US$): 3001 - Glands, organs (extracts, secretions thereof) for organo-therapeutic uses, dried, powdered or not; heparin and its salts; other human or animal substances for therapeutic or prophylactic uses n.e.s.
The value of imports of commodity group 30 "Pharmaceutical products" to Switzerland totalled $ 58 billion in 2023. Sales of commodity group 30 to Switzerland went up by 20% compared to 2022: imports of commodity group 30 "Pharmaceutical products" went up by $ 9.78 billion (the value of imports of commodity group 30 to Switzerland was equal to $48 billion in 2022)
Imports of commodity group 30 "Pharmaceutical products" accounted for 16% of total import flow to Switzerland (in 2023, total imports to Switzerland amounted to $ 365 billion). The share of commodity group 30 in total imports to Switzerland increased by 2.33 p.p. compared to 2022 (it was 13.6% in 2022 and cumulative imports to Switzerland were equal to $ 356 billion).
Where does Switzerland import Pharmaceutical products from?
Top trading partners (import of "Pharmaceutical products") of Switzerland in 2023:
- Slovenia with a share of 21% (12.5 billion US$)
- Germany with a share of 17.7% (10.3 billion US$)
- Italy with a share of 12.3% (7.19 billion US$)
- Spain with a share of 9.89% (5.78 billion US$)
- USA with a share of 8.61% (5.03 billion US$)
- Ireland with a share of 6.15% (3.6 billion US$)
- Austria with a share of 5.34% (3.12 billion US$)
- Singapore with a share of 4.53% (2.64 billion US$)
- Japan with a share of 3.27% (1.91 billion US$)
- Korea with a share of 2.66% (1.55 billion US$)
Imports structure of 30 - Pharmaceutical products - to Switzerland in 2023 represented by the following main commodity groups:
- 68% (40 billion US$): 3004 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale
- 29% (17.5 billion US$): 3002 - Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc
- 0.649% (379 million US$): 3003 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale
- 0.538% (314 million US$): 3006 - Pharmaceutical goods specified in Note 4 to this Chapter.
- 0.234% (137 million US$): 3005 - Wadding, gauze, bandages and similar articles (for example, dressings, adhesive plasters, poultices), impregnated or coated with pharmaceutical substances or put up in forms or packings for retail sale for medical, surgical, dental or veterinary purposes.
- 0.055% (32 million US$): 3001 - Glands, organs (extracts, secretions thereof) for organo-therapeutic uses, dried, powdered or not; heparin and its salts; other human or animal substances for therapeutic or prophylactic uses n.e.s.
